Invitrogen™ Human TMEM106A Synthetic Peptide

Ref.: BL-RE-176225Manufacturer ref.: PEP-1395 50 μg
€149.00 excl. VAT

TMEM106A Synthetic Peptide, PEP-1395, from Invitrogen.

Gene ID (Enter)
113277
Species
Human
Purification method
Purified
Accession number
Q96A25
Common name
Human TMEM106A
Brand
Invitrogen

TMEM106A Synthetic Peptide, PEP-1395, from Invitrogen.

TMEM106A Synthetic Peptide, PEP-1395, from Invitrogen.

Transmembrane protein 106A (TMEM106A) is a single-pass transmembrane protein that is closely related to TMEM106B, a protein that is thought to be a novel risk factor for frontotemporal lobar degeneration (FTLD), a group of clinically, pathologically and genetically heterogeneous disorders associated with atrophy in the frontal lobe and temporal lobe of the brain. The actual roles of TMEM106A and TMEM106B are still undetermined; however, as TMEM106B is involved in FTLD, it is possible that TMEM106A may also be a risk factor for FTLD.

Species

Species: Human.

Conservation

Storage: -20°C.

Formulation

Concentration: 200 μg/mL.

Regulatory status

Research only (RUO).

Packaging

Packaging: 50 μg.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)15205309
Specifications
Gene ID (Enter)113277
SpeciesHuman
Purification methodPurified
Accession numberQ96A25
Common nameHuman TMEM106A
Concentration200 μg/mL
DescriptionSynthetic Peptide
FormatLiquid
FormulaPBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
For use with (application)Blocking Assay, Control
Gene symbol(s)TMEM106A
LyophilizedNo
Product typePeptide
Quantity50 μg
Regulatory statusRUO - research use only
Storage and shipping
Content and storage-20°C
Conservative0.02% sodium azide
Storage stampPBS

Origin and customs

Manufacturer ref.PEP-1395
Country of originUnited States
HS customs code3824 99 92 00
A question or a specific configuration?
Contact us for a quote.